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Abstract
The protein kinase mammalian target of rapamycin (mTOR) regulates the phosphorylation and activity of several proteins
that have the potential to control translation, including p70S6 kinase and the eIF4E binding proteins 4E-BP1 and 4E-BP2. In
spite of this, in exponentially growing cells overall protein synthesis is often resistant to mTOR inhibitors. We report here
that sensitivity of wild-type mouse embryonic fibroblasts (MEFs) to mTOR inhibitors can be greatly increased when the cells
are subjected to the physiological stress imposed by hypertonic conditions. In contrast, protein synthesis in MEFs with a
double knockout of 4E-BP1 and 4E-BP2 remains resistant to mTOR inhibitors under these conditions. Phosphorylation of
p70S6 kinase and protein kinase B (Akt) is blocked by the mTOR inhibitor Ku0063794 equally well in both wild-type and 4E-
BP knockout cells, under both normal and hypertonic conditions. The response of protein synthesis to hypertonic stress
itself does not require the 4E-BPs. These data suggest that under certain stress conditions: (i) translation has a greater
requirement for mTOR activity and (ii) there is an absolute requirement for the 4E-BPs for regulation by mTOR. Importantly,
dephosphorylation of p70S6 kinase and Akt is not sufficient to affect protein synthesis acutely.
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Introduction
The polypeptide chain initiation factor eIF4E plays an
important role in regulating the translation of capped mRNAs in
eukaryotic cells and it is widely accepted that the availability of
eIF4E to form the eIF4F initiation complex (comprising eIF4E, the
large scaffold protein eIF4G and the RNA helicase eIF4A) can be
a rate-limiting step in the initiation of protein synthesis [1]. The
eIF4E-binding proteins 4E-BP1 and 4E-BP2 can bind eIF4E in
competition with eIF4G and thus limit the formation of the eIF4F
complex [2].
Initiation factor eIF4E is now considered to be a bone fide
oncogene product [3], based on data from transgenic mouse
studies [4] and the fact that many cancers have enhanced levels
and/or activity of the protein [5]. High levels of eIF4E are able to
confer resistance to apoptosis in cells exposed to a variety of death
stimuli [6,7], and eIF4E activity is regulated by the anti-apoptotic
protein kinase Akt, an enzyme implicated in tumour cell survival
and resistance to therapy [8]. Since the 4E-BPs inhibit the function
of eIF4E by competing for the binding of eIF4G these small
proteins often have opposite effects to those of eIF4E. Thus the
4E-BPs can revert the transformed phenotype in cells over-
expressing eIF4E [9]. Moreover, cell cycle progression is blocked
by over-expression of 4E-BP1 [10], most likely due to changes in
the expression of proteins that regulate passage through the cell
cycle. Consistent with this, 4E-BP1 can prevent the progression of
cells from the G1 phase into S phase of the cell cycle without
affecting the increases in cell mass or protein content characteristic
of passage of cells through G1 [11]. Experimental knockdown of
4E-BP1 relieves the inhibition of cell cycle progression induced by
cellular stresses such as hypoxia [12]. It is likely that an important
mechanism of action of 4E-BP1 as an anti-oncogenic factor
involves the induction of apoptosis, providing a counter-balance to
the cell survival-promoting effects of eIF4E. Paradoxically,
however, cells with decreased 4E-BP1 expression are less able to
survive physiological stresses such as exposure to hypoxia or
ionizing radiation [13], and it is possible that the inhibition of
translation caused by disruption of eIF4F complex formation
during hypoxia [14] may have a protective effect. A role for the
4E-BPs as factors that protect cells (and thus favour cell survival)
under conditions of physiological stress has been suggested in
earlier studies [15]. Relevant to this is the fact that the expression
of 4E-BP1 (both phosphorylated and unphosphorylated) is
elevated in a variety of tumours showing malignant progression
[16].
The ability of the 4E-BPs to bind eIF4E is regulated by their
state of phosphorylation, which in turn is controlled by the protein
kinase mammalian target of rapamycin (mTOR). The latter exists
in two complexes, mTORC1 and mTORC2, and is important in
the control of a wide variety of pathways in health and disease
[17]. In addition to the 4E-BPs, substrates for the mTOR
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complexes include the protein kinases p70S6 kinase [18] and Akt/
protein kinase B [19]. Although these regulatory mechanisms are
well understood it has been somewhat puzzling that inhibition of
mTOR activity, which leads to the dephosphorylation of the 4E-
BPs and marked inhibition of eIF4F assembly, often has little or no
effect on the rate of overall protein synthesis in mammalian cells
[20]. A possible interpretation of these observations is that, under
optimal conditions, there is little requirement for cap binding by
the eIF4F complex for the continuing translation of the majority of
mRNAs. This may be a consequence of the functional ‘‘circular-
ization’’ of polysomes, in which the 39 end of the mRNA becomes
associated with the 59 end, allowing direct reinitiation of
translation without the need for eIF4E to interact again with the
cap structure [21]. We have hypothesized that cellular stresses that
inhibit translation and lead to the disruption of polysome
circularization should therefore increase the dependence on eIF4E
and thus sensitize protein synthesis to inhibition of mTOR. Using
the allosteric mTOR inhibitor rapamycin, the active site inhibitors
Ku-0063794 [22] and PP242 [23] and the dual PI3-kinase/
mTOR inhibitor PI-103 under conditions of optimal growth or
physiological stress (hypertonic conditions or serum deprivation),
we now provide evidence that supports this hypothesis. Moreover,
although mTORC1 and mTORC2 have many direct and indirect
substrates and targets, several of which have the potential to
regulate global rates of protein synthesis, our data show that the
acute effects of mTOR inhibition on translation require the 4E-
BPs and that the dephosphorylation of other key mTOR
substrates is not sufficient to impair overall protein synthesis, at
least in the short term. These findings are relevant to our
understanding of the role of the 4E-BPs in regulating the
malignant phenotype, as well as the therapeutic responses to
mTOR inhibitors of tumour cells with deregulated PI3-kinase, Akt
or mTOR activity.
Methods
Materials
Tissue culture materials were from Gibco Life Technologies
Ltd. (Paisley, U.K.) and GE Healthcare (Little Chalfont, U.K.).
The mTOR inhibitors Ku-0063794, rapamycin, PP242 and PI-
103 were from Tocris Bioscience (Bristol U.K.). m7GTP-Sephar-
ose beads were from GE Healthcare. [35S]methionine was
supplied by MP Biomedicals (Cambridge, U.K.). Antibodies
against total 4E-BP1 and phosphorylated 4E-BP1 (Ser64) were
from Santa Cruz Biotechnology Inc. (Heidelberg, Germany) and
Cell Signalling Technology (Hitchin, Herts, UK) respectively.
Antibodies against total Akt and phosphorylated Akt (Ser473) and
against total p70S6K and phosphorylated p70S6K (Thr389 and
Thr421/Ser424) were from Cell Signalling Technology. The
antibody against GAPDH was from Merck Millipore (Feltham,
U.K.). Anti-eIF4GI was produced in-house. Horseradish perox-
idise-linked secondary antibodies were from Cell Signalling
Technology. PVDF membrane and rainbow markers were
supplied by GE Healthcare.
Cell Lines
Mouse embryonic fibroblasts (MEFs) with a double knockout of
the 4E-BP1 and 4E-BP2 genes [24] and their corresponding wild-
type controls were a gift from Dr Nahum Sonenberg (McGill
University, Montreal, Canada). MEFs with a Ser to Ala mutation
at position 51 of the eIF2a gene (S51A cells) [25] and their
corresponding wild-type controls were a gift from Dr Randall
Kaufman (Wayne State University, Ann Arbor, Michigan, USA).
Cell Culture and Treatments
The cells were maintained in monolayer cultures at 37uC in
humidified air with 5% CO2 in Dulbecco’s modified Eagle
medium supplemented with penicillin (50 units/ml), streptomycin
(50 units/ml) and 10% foetal bovine serum. Cultures were split
every 3–5 days and all experiments were performed on cells that
were in exponential growth. To induce hypertonic stress the cells
were incubated for 1 h in the above medium containing additional
NaCl (0.1 M except where otherwise indicated). For experiments
involving serum deprivation the cells were washed with phosphate
buffered saline (PBS) and then incubated in the above medium
with or without serum for 24 h. The cells were then incubated
without or with rapamycin (100 nM), Ku-0063794 (1 mM), PP242
(5 mM) or PI-103 (5 mM) for 1 h.
Protein Synthesis
Following the treatments described above overall protein
synthesis in intact cells was measured by the incorporation of
[35S] methionine (1–2 mCi/ml for 1 h) into trichloroacetic acid-
insoluble material as described previously [26]. Total cellular
protein content was determined and rates of protein synthesis
calculated as counts per min incorporated per mg protein.
Immunoblotting
Cells were washed in PBS and subjected to lysis as previously
described [27]. Nuclei were removed by centrifugation, equal
amounts of cytoplasmic protein were fractionated by electropho-
resis on sodium dodecyl sulphate (SDS) polyacrylamide gels and
the proteins were then transferred to PVDF paper. The blots were
blocked, incubated with primary antibodies, thoroughly washed
and then incubated with horseradish peroxidase-linked secondary
antibodies as described [27]. Binding of the latter was detected by
enhanced chemiluminescence, using Lumiglo reagent (Cell Sig-
nalling Technology) according to the manufacturer’s instructions.
m7GTP-Sepharose Affinity Purification
Initiation factor eIF4E and its associated proteins were isolated
from cell extracts (containing equal concentrations of protein) by
affinity chromatography on m7GTP-Sepharose beads as described
[28]. The beads were washed thoroughly with ice-cold buffer
(20 mM MOPS-KOH, pH 7.4, 75 mM NaCl, 1 mM Mg acetate,
7 mM 2-mercaptoethanol, 0.25% Igepal, 1 mM microcystin,
2 mM benzamidine, 0.1 mM GTP, 10 mM NaF) and the bound
proteins eluted with SDS gel sample buffer. The proteins were
then analyzed by immunoblotting as described above.
Statistical Analysis of Data
The data from the protein synthesis determinations are shown
as the means 6 S.E.M. Independent experiments were performed
at least three times and typical examples are presented. Unpaired t
tests (Prism 3 software, GraphPad) were used to determine
statistical significance and p values of ,0.05 are considered to
demonstrate significant differences.
Results
It is well established that the stress imposed on cells by mildly
hypertonic conditions results in a marked inhibition of protein
synthesis. However the consequences of inhibition of mTOR
activity under such conditions have not previously been examined.
Accordingly we investigated the effect of the mTOR inhibitor Ku-
0063794 on translation in murine embryonic fibroblasts in the
presence of increasing salt concentrations. Figure 1A (left panel)
confirms the sensitivity of overall protein synthesis in wild-type
Translation during Stress and mTOR Inhibition
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MEFs to the hypertonic conditions imposed by additional NaCl in
the culture medium. The data show that whereas Ku-0063794
had only a small effect under normal salt conditions, which was
not statistically significant, in the presence of additional NaCl
(0.1 M or greater) the effect of Ku-0063794 was substantially
increased (50–60% inhibition – statistically significant, p,0.005).
The effects on protein synthesis of the mTOR inhibitor in the
presence and absence of hypertonic conditions were also analysed
by analysis of the distributions of ribosomes between polysomes
and sub-polysomal fractions on sucrose gradients. Whereas there
was very little decrease in the % of ribosomes in polysomes in
response to 0.1 M NaCl or 1 mM Ku-0063794 individually, there
was a noticeably greater effect when the cells were exposed to both
treatments together (data not shown).
To determine the requirement for the 4E-BPs for the effects of
Ku-0063794 on protein synthesis under normal and hypertonic
conditions, similar experiments were performed on 4E-BP1/2
double knockout (DKO) cells. The latter cells are genetically
disrupted for both 4E-BP1 and 4E-BP2 and express neither of
these proteins [24]. The absence of 4E-BP1 is confirmed by the
immunoblot shown in Figure 1B. The data in Figure 1A (right
panel) demonstrate that protein synthesis in the DKO cells was
just as sensitive as in 4E-BP wild-type cells to inhibition by
hypertonic conditions; however, in these cells there was no
significant effect of Ku-0063794 under any of the salt conditions
tested. The relative responses of the wild-type and DKO cells to
Ku-0063794 at different salt concentrations, as determined by
[35S]methionine incorporation, are summarized in Figure 1C.
Similar experiments were carried out using MEFs with a serine
to alanine mutation at position 51 of the a subunit of initiation
factor eIF2 (S51A cells). These cells are unable to undergo
phosphorylation at this site in response to a variety of physiological
stresses, rendering them deficient in the regulation of polypeptide
chain initiation [25]. Protein synthesis in the S51A cells remained
sensitive to inhibition by increasing concentrations of NaCl (data
not shown), indicating that phosphorylation of eIF2a is not
required for the effect of hypertonic conditions on translation.
Moreover, hypertonic conditions still significantly enhanced the
Figure 1. Influence of salt concentration on the inhibition of protein synthesis by Ku-0063794 in 4E-BP wild-type cells and cells with
a double knockout of 4E-BP1 and 4E-BP2. (A) Wild-type and DKO MEFs were pre-incubated in complete medium in the presence of additional
NaCl at the concentrations indicated. After 1 h the cells were further incubated with or without Ku-0063794 (1 mM) for 1 h and total protein synthesis
was then measured by the incorporation of [35S]methionine (2 mCi/ml) for 1 h as described in Experimental. The data are the means of triplicate
determinations and are expressed as counts per min incorporated per mg of protein 6 S.E.M. Significances of differences between incubations 6 Ku-
0063794 were determined by unpaired t tests: * = p,0.005; N.S. = not significant. (B) Extracts from 4E-BP wild-type and DKO cells were analysed for
expression of 4E-BP1 by immunoblotting. Blots for GAPDH are also shown as loading controls. (C) Summary of % inhibition of protein synthesis by
Ku-0063794 in 4E-BP wild-type (wt) and DKO cells as a function of the additional NaCl concentration.
doi:10.1371/journal.pone.0071138.g001
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effect of Ku-0063794 on protein synthesis in the S51A cells, unlike
the situation with the 4E-BP DKO cells (Table 1). Overall, these
data indicate that hypertonic conditions inhibit protein synthesis
by a mechanism that requires neither inhibition of eIF4E by 4E-
BP1/2 nor phosphorylation of eIF2a by stress-sensitive kinases,
whereas the effect of Ku-0063794 under hypertonic conditions
does require the presence of 4E-BP1 and/or 4E-BP2 but is
independent of eIF2a phosphorylation.
We have extended these experiments to examine the effects of
other mTOR inhibitors on overall protein synthesis in the absence
or presence of additional salt. The well characterised mTORC1
inhibitor rapamycin failed to inhibit [35S]methionine incorpora-
tion at all under normal conditions but reduced protein synthesis
by 29% in 4E-BP wild-type cells under hypertonic conditions
(statistically significant, p,0.002) (Fig. 2A). As noted by others
[29,30], rapamycin was less effective than mTOR kinase inhibitors
such as Ku-0063794, probably because there are rapamycin-
resistant functions of mTORC1 [31]. In confirmation of the
previous data, the DKO cells were completely resistant to
inhibition of mTOR by either rapamycin or Ku-0063794 under
both normal and hypertonic conditions (Fig. 2B). Similar results
were obtained with the mTORC1/2 inhibitor PP242. In this case,
the effect of the drug in 4E-BP wild-type cells was increased from
30% inhibition under normal conditions to 65% inhibition under
hypertonic conditions (statistically significant). PP242 did not
inhibit protein synthesis at all in DKO cells under either condition
(our unpublished data).
Another compound that inhibits not only mTORC1/2 but also
PI3-kinase is the pyridofuropyrimidine PI-103 [32]. We examined
the sensitivity of overall protein synthesis to PI-103 in 4E-BP wild-
type and DKO MEFs under both normal and hypertonic
conditions (Fig. 3). Protein synthesis under optimal growth
conditions was moderately inhibited by PI-103 in both cell types
(20.9610.2% and 34.662.8% inhibition respectively). However,
as we observed with the other mTOR inhibitors, in the wild-type
cells the presence of additional 0.1 M NaCl enhanced the
inhibition by PI-103 (57.064.9%). This enhancement was
statistically significant (p,0.01). Again there was no enhancement
of inhibition by hypertonic conditions in the DKO cells
(20.263.0% inhibition). These data indicate that, although PI-
103 can partially inhibit protein synthesis in the absence of 4E-BP1
and 2 (presumably as a consequence of the inhibition of PI3-kinase
activity), the 4E-BPs are needed for the salt-mediated enhance-
ment of inhibition by PI-103.
Since 4E-BP1, when in a hypophosphorylated state, regulates
cap-dependent translation by competing with eIF4G for binding to
eIF4E, it was important to determine whether hypertonic
conditions influence the state of phosphorylation of this protein.
Figure 4 shows that, in the absence of Ku-0063794, 4E-BP1 in
wild-type cells remained in a predominantly phosphorylated state
under the higher salt conditions, as judged both by its mobility on
SDS gels and by reactivity of the protein with an antibody against
the Ser64 phosphorylation site. This is consistent with evidence
that mTOR remains active under hypertonic conditions and
indeed may be activated by osmotic stress [33,34]. Incubation of
the cells with Ku-0063794 caused extensive dephosphorylation of
4E-BP1, under both normal and hypertonic conditions. The
immunoblots also revealed evidence of cleavage of 4E-BP1 in wild-
type cells in the presence of Ku-0063794 but this was not
enhanced by the higher salt conditions. Instead a stronger band
corresponding to intact hypophosphorylated 4E-BP1 was seen.
Consistent with the effect of Ku-0063794 on the state of
phosphorylation of 4E-BP1, binding of the latter to eIF4E was
strongly stimulated in the presence of the mTOR inhibitor (Fig. 5).
Conversely, the association of eIF4GI with eIF4E in the eIF4F
complex was completely eliminated by Ku-0063794, both under
normal and hypertonic conditions. Additional NaCl alone had no
effect on binding of eIF4GI to eIF4E (Fig. 5).
As expected, a 4E-BP1 signal was absent from the DKO cell
extracts, although a faint band of slightly slower mobility was
detected (Fig. 4). Since this protein cross-reacted with antibodies
against both total 4E-BP1 and Ser64, and was dephosphorylated in
the presence of Ku-0063794, it may correspond to 4E-BP3. There
was no 4E-BP signal under any conditions when eIF4E and its
associated proteins in DKO cells were analysed by immunoblot-
ting (Fig. 5). In spite of this, some decrease in the association of
eIF4GI with eIF4E occurred in these cells in the presence of Ku-
0063794, although this was clearly not sufficient to impair overall
protein synthesis (Figs. 1 and 2). Taken in combination with the
protein synthesis results, these findings suggest that Ku-0063794-
mediated dephosphorylation of 4E-BP1 and the consequent
inhibition of eIF4F complex formation are not sufficient to inhibit
overall translation in the short term. Moreover, the sensitization to
Ku-0063794 in hypertonically stressed cells does not involve any
greater extent of dephosphorylation of 4E-BP1 or inhibition of
Table 1. Contrasting requirements for 4E-BP expression or eIF2a phosphorylation for inhibition of protein synthesis by Ku
0063794 under normal and hypertonic conditions.
Cell line Conditions % inhibition of protein synthesis by Ku-0063794
4E-BP wild-type Normal 8.364.7
4E-BP wild-type Hypertonic 56.362.9 (p,0.0001)*
DKO Normal 3.263.4
DKO Hypertonic 3.462.4 (not significant)*
S51 wild-type Normal 23.6612.1
S51 wild-type Hypertonic 63.666.0 (p = 0.01)*
S51A Normal 34.064.5
S51A Hypertonic 47.864.6 (p = 0.05)*
The indicated cell lines were pre-incubated in complete medium in the absence or presence of additional 0.1 M NaCl. After 1 h the cells were further incubated with or
without Ku-0063794 (1 M) for 1 h and total protein synthesis was then measured by the incorporation of [35S]methionine (2 mCi/ml) for 1 h as described in
Experimental. The data are the means of 6–9 independent determinations. Asterisks show the significance of the differences between the effects of Ku-0063794 on
protein synthesis under normal versus hypertonic conditions.
doi:10.1371/journal.pone.0071138.t001
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eIF4GI binding to eIF4E (the latter being completely eliminated
by Ku-0063794 alone).
The lack of response of protein synthesis to mTOR inhibitors in
the DKO cells indicates that 4E-BP1 and/or 4E-BP2 are
necessary for the acute regulation of overall translation by the
protein kinase. However, mTOR has many other targets with the
potential for the control of protein synthesis and it was of interest
to determine whether the regulation of these targets is disrupted in
DKO cells. One such substrate is p70S6 kinase, which phosphor-
ylates ribosomal protein S6 as well as several other proteins [35].
Immunoblotting analysis revealed that the phosphorylation of
p70S6 kinase, both at Thr421/Ser424 and at Thr389– sites which
regulate the activity of the enzyme [36] - was strongly inhibited by
Ku-0063794 in 4E-BP wild-type and DKO cells, under both
control and hypertonic conditions (Figure 4). Thus inhibition of
the activity of p70S6 kinase is not sufficient to cause rapid down-
regulation of overall protein synthesis. A similar conclusion can be
drawn with respect to the mTORC2 substrate Akt (Figure 4).
Thus, although phosphorylation of Akt at Ser473 regulates the
ability of this enzyme to control long-term cellular responses such
as proliferation and survival [37], these effects can be dissociated
from the acute control of overall translation by mTOR in mouse
fibroblasts.
We have investigated whether the sensitization of cells to the
effects of mTOR inhibitors is specific to hypertonic conditions or
whether other cell stresses may have similar effects. Figure 6 shows
that serum starvation also sensitizes 4E-BP wild-type cells to
inhibition of protein synthesis by Ku-0063794. In the experiment
shown, although the wild-type cells had some sensitivity to the
mTOR inhibitor under unstressed conditions (28% inhibition), the
effect of Ku-0063794 was markedly increased after 24 h of serum
deprivation (55% inhibition, significantly different from the value
for the cells in the presence of serum, p= 0.0005). Again there was
no significant inhibition by Ku-0063794 in the DKO cells, in the
absence or presence of serum. These data suggest that at least
some stresses other than hypertonicity, including the important
one of growth factor deprivation, can also increase the sensitivity
of overall protein synthesis to the regulation of the 4E-BPs by
mTOR.
Discussion
It has been known for many years that hypertonic conditions
reversibly inhibit protein synthesis in mammalian cells [38] and a
number of studies have addressed the molecular mechanisms and
signalling pathways involved [39–41]. In spite of this work the
basis for the inhibition of translation by additional salt remains
unclear since neither of the principal mechanisms by which
polypeptide chain initiation is regulated appear to be involved.
Figure 2. Comparison of the effects of Ku-0063794 and
rapamycin on protein synthesis in 4E-BP wild-type and 4E-
BP-deficient cells under normal and hypertonic conditions. (A)
Wild-type cells and (B) DKO cells were pre-incubated in complete
medium in the absence or presence of additional 0.1 M NaCl. After 1 h
the cells were further incubated with or without Ku-0063794 (1 mM) or
rapamycin (100 nM) for 1 h and total protein synthesis was then
measured by the incorporation of [35S]methionine (2 mCi/ml) for 1 h as
described in Experimental. The data are the means of triplicate
determinations and are expressed as counts per min incorporated per
mg of protein 6 S.E.M. Significances of differences between incubations
with and without each mTOR inhibitor were determined by unpaired t
tests: * = p,0.002; ** = p,0.0001; N.S. = not significant.
doi:10.1371/journal.pone.0071138.g002
Figure 3. Influence of salt concentration on the inhibition of
protein synthesis by PI-103. 4E-BP wild-type and DKO cells were
incubated in complete medium in the absence or presence of
additional 0.1 M NaCl. After 1 h the cells were further incubated with
or without PI-103 (5 mM) for 1 h and total protein synthesis was then
measured by the incorporation of [35S]methionine (2 mCi/ml) for 1 h as
described in Experimental. The data are the means 6 S.E.M of 9
independent determinations on 4E-BP wild-type cells and 6 indepen-
dent determinations on DKO cells and are expressed as the % inhibition
of protein synthesis by PI-103 in the absence or presence of the
additional NaCl. Significance of difference was determined by unpaired
t test: * = p,0.01.
doi:10.1371/journal.pone.0071138.g003
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High salt treatment does not cause any increase in the
phosphorylation of the a subunit of initiation factor eIF2 [39]
(and our unpublished data), nor any decrease in the formation of
[40S ribosomal subunit.Met-tRNAf] initiation complexes [42],
and cells with a non-phosphorylatable form of eIF2a (S51A MEFs)
are no less susceptible than S51 wild-type cells to salt-mediated
inhibition of protein synthesis (data not shown). This would
suggest that a subsequent step in the initiation process, such as
mRNA binding to ribosomes, is impaired. However our present
work rules out a role for 4E-BP1 or 4E-BP2, and thus by
implication the availability of the cap binding factor eIF4E, in the
effect. This is consistent with the lack of any major effect of higher
salt conditions on the state of phosphorylation of 4E-BP1 (Fig. 4),
or on the association of the latter with eIF4E (Fig. 5), and with the
ability of protein synthesis to recover from salt-mediated inhibition
under conditions where the phosphorylation of 4E-BP1 is blocked
[41]. Our results differ from those of Kwak et al. [34], who
reported dephosphorylation of both 4E-BP1 and p70S6K in
response to osmotic stress induced by sorbitol treatment of 293
cells. However these discrepancies may be a result of the use of
different cell types or different means of inducing the cell stress.
The present work also shows that inhibition by mildly
hypertonic conditions is not associated with acute dephosphory-
lation of p70S6K or Akt (Fig. 4). This is consistent with the
reported dissociation of the kinetics of translation activity and
p70S6K activity (as measured by S6 phosphorylation) in cells
inhibited by or recovering from salt shock [38]. A recent report
shows that mTOR remains active under moderately hypertonic
conditions [33]. Thus it is unlikely that regulation of mTOR or its
downstream targets is responsible for the effect of high salt on
translation. Current evidence suggests a role for the protein kinases
MEK1/2 in the regulation of protein synthesis by hypertonicity
[41] but further work is clearly needed in this area.
As reported previously [20,29], mTOR inhibitors have a
relatively small effect on protein synthesis in cells under non-
stressed conditions. Active site inhibitors such as Ku-0063794 and
PP242 are more potent than rapamycin [29,30], but even these
compounds did not inhibit translation by more than 30% in
exponentially growing MEFs (Fig. 1). Similar findings were
obtained with the dual PI3-kinase/mTOR inhibitor PI-103
(Fig. 3). Such observations suggest that in exponentially growing
cells the synthesis of the majority of proteins shows little
requirement for free eIF4E (i.e. the form of the factor that can
be sequestered by the 4E-BPs). Indeed it has been shown that 80%
knockdown of eIF4E only inhibits global protein synthesis by 20%
[43]. The basis for this remains to be established but one possibility
is the functional ‘‘circularization’’ of polysomal mRNA [21], so
that terminating ribosomes may be able to reattach to the 59 end
because the mRNA remains associated with eIF4G, with the need
for cap recognition by eIF4E being by-passed altogether [44]. In
contrast, under conditions where polypeptide chain initiation is
disrupted by stress such reattachment may be inhibited, thus
establishing a greater requirement for free eIF4E for reinitiation.
Consistent with this, mRNA has been shown to dissociate from
ribosomes and accumulate as free mRNP complexes under
hypertonic conditions [45]. The increased dependency on eIF4E
is not specific to salt treatment since we have shown that the stress
of serum deprivation also sensitizes cells to the effects of mTOR
inhibitors. However a number of other stress conditions, including
DNA damage, endoplasmic reticulum stress and chemical
hypoxia, do not appear to sensitize cells to Ku-0063794 (our
unpublished data). There are several putative mechanisms for the
lower probability of mRNA-ribosome binding under certain stress
conditions, such as reduced stability of protein-protein interactions
or protein-mRNA interactions, and these require further investi-
gation to establish the basis for the stress-induced sensitivity to
mTOR inhibitors.
The experiments reported here concern the control of overall
protein synthesis and do not address the issue of likely variations in
the translation of individual mRNA species in response to cell
stress and/or mTOR inhibition. Earlier studies have shown that
hypertonic conditions or the recovery from such conditions have
differential effects on the synthesis of different proteins [46].
Likewise, mTOR inhibitors impair the translation of some
mRNAs much more than that of others [47], with mRNAs
possessing a 59 terminal oligopyrimidine sequence or similar motif
being particularly sensitive [30,48]. Recently it has been shown
that the translation of mRNAs encoding proteins involved in the
invasive and metastatic properties of cancer cells is directly
regulated by mTOR [49]. On the other hand, the mRNA
encoding the p53 regulator mdm2 is particularly rapamycin-
resistant [50]. The protocol of mild hypertonicity and mTOR
inhibitor treatment described in this paper now provides a means
to assess the relative eIF4E requirements of mRNAs with different
59 UTRs, using either transfection of reporter constructs or a more
global approach involving ribosome profiling and micro-array
analysis [51].
Figure 4. Inhibition of phosphorylation of 4E-BP1, p70S6
kinase and Akt by Ku-0063794 under normal and hypertonic
conditions. 4E-BP wild-type and DKO MEFs were pre-incubated in
complete medium in the absence or presence of additional 0.1 M NaCl.
After 1 h the cells were further incubated with or without Ku-0063794
(1 mM) for 1 h and extracts were prepared. The extracts were analysed
for total 4E-BP1 and phosphorylated 4E-BP1 (Ser64), total and
phosphorylated Akt (Ser473), and total and phosphorylated p70S6kinase
(Thr421/Ser424 and Thr389) by SDS gel electrophoresis and immunoblot-
ting. The positions of the differentially phosphorylated a, b and c forms
and of a cleavage product of 4E-BP1 are indicated. Blots for GAPDH are
also shown as loading controls.
doi:10.1371/journal.pone.0071138.g004
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Many previous studies have established the key role of the 4E-
BPs as regulators of protein synthesis downstream of mTOR, and
our demonstration that there is an absolute requirement for 4E-
BP1/2 for the response to inhibitors of mTOR is in accord with
this. It also shows that the likely presence (and apparent
dephosphorylation) of 4E-BP3 is not sufficient to compensate for
the lack of 4E-BP1 and 4E-BP2 in sensitizing cells to mTOR
inhibition. In addition, our data show that the decreased
phosphorylations of p70S6K and Akt that occur when
mTORC1/2 activity is inhibited are not sufficient to affect overall
protein synthesis, at least in the short term. Thus these proteins (as
well as other mTOR substrates [52]) are unlikely to play a role in
the acute control of overall translation. However we wish to
emphasize that, whatever the relative importance of the various
Figure 5. Inhibition of eIF4F complex formation by Ku-0063794 under normal and hypertonic conditions. 4E-BP wild-type and DKO
MEFs were pre-incubated in complete medium in the absence or presence of additional 0.1 M NaCl. After 1 h the cells were further incubated with or
without Ku-0063794 (1 mM) for 1 h and extracts were prepared. Using equal quantities of total protein, the extracts were then subjected to affinity
chromatography on m7GTP-Sepharose to isolate eIF4E and its associated proteins, as described in Experimental. The bound proteins were analysed
for eIF4E, 4E-BP1 and eIF4GI by SDS gel electrophoresis and immunoblotting.
doi:10.1371/journal.pone.0071138.g005
Figure 6. Effect of Ku-0063794 on protein synthesis in 4E-BP wild-type and 4E-BP deficient cells under normal and serum-deprived
conditions. Wild-type and DKO cells were incubated for 24 h in complete medium or in medium lacking serum. The cells were incubated with or
without Ku-0063794 (1 mM) for 1 h and overall protein synthesis was then measured by the incorporation of [35S]methionine (1 mCi/ml) for 1 h as
described in Experimental. The data are the means of triplicate determinations and are expressed as counts per min incorporated per mg of protein6
S.E.M. Significances of differences between incubations 6 Ku-0063794 were determined by unpaired t tests: * = p,0.05; N.S. = not significant.
doi:10.1371/journal.pone.0071138.g006
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mTOR targets for the control of translation, none of these proteins
– including 4E-BP1 and 4E-BP2– is effective under optimal
growth conditions, at least in fibroblasts. Only under conditions of
stress such as hypertonicity or serum deprivation does a role for
the 4E-BPs become relevant. The lack of effect of p70S6K and Akt
on overall translation is perhaps surprising since these protein
families have several direct or indirect targets with potential roles
in the regulation of protein synthesis [53]. Nevertheless a previous
report [54] has also demonstrated that inhibition of p70S6K by
rapamycin is not sufficient to inhibit cap-dependent translation. In
the case of Akt, targets include not only mTOR itself [55] but also
many other factors that control cell proliferation and survival
(reviewed in [37]). The lack of a major effect of Akt on the protein
synthetic machinery is suggested by the relatively small effect of PI-
103 on translation under normal salt conditions, in spite of the fact
that this compound has profound effects on Akt activity as a
consequence of its inhibition of PI3-kinase [56]. However, our
results do not rule out an important role for mTOR targets other
than the 4E-BPs in the longer term effects of mTOR inhibitors on
translation. Indeed, 24 h exposure to Ku-0063794 under normal
salt conditions did cause a 30% reduction in protein synthesis in
the DKO cells (versus 55% inhibition in 4E-BP wild-type cells)
(data not shown). It is also possible that changes in the
phosphorylation state of p70S6K and/or Akt and their targets
may be important for the rapid regulation of the translation of
individual mRNA species, via mechanisms that are independent of
the 4E-BPs. In this connection it is of interest that Ku-0063794 did
cause a partial impairment of eIF4F complex formation in the
DKO cells (Fig. 5).
Recent reports using cell lines in which the levels of 4E-BP1 and
4E-BP2 have been experimentally manipulated show that these
proteins play important roles in the regulation of cell proliferation
[57], contact inhibition [58] and p53-dependent cell senescence
[24]. In contrast, the regulation of cell growth (as opposed to
proliferation) by mTOR does not involve the eIF4E binding
proteins but does require S6 kinase activity [57]. It is probable that
the control of cell proliferation by the 4E-BPs is a reflection of
changes in the synthesis of key regulatory proteins whose mRNAs
have a high requirement for eIF4E. Nevertheless our present data
also indicate a more general role for the 4E-BPs in the control of
overall protein synthesis under conditions of stress. These results
may be of significance for our understanding of the role of the 4E-
BPs in cancer. Physiological stress conditions often prevail in
tumours in vivo due to lack of oxygen and nutrient supplies and
malignant cells can evolve strategies to overcome such adverse
conditions. In view of the importance of the 4E-BPs for the control
of proliferation of untransformed cells, as well as the well known
role of dysregulation of the eIF4E/4E-BP system in cancer
progression [59,60], it would be of interest to determine whether
the sensitivity of protein synthesis and cell proliferation to mTOR
inhibitors under stress conditions is diminished in transformed cells
relative to their normal counterparts and whether this is
determined by the relative levels of eIF4E versus the 4E-BPs in
these cells. Thus the higher levels or activity of eIF4E often found
in tumour cells may not only enhance the synthesis of growth-
promoting or anti-apoptotic proteins (translated from relatively
‘‘weak’’ mRNAs) but also desensitize the cells to physiological
stresses and the inhibition of mTOR. These considerations may
provide guidelines for predicting the extent to which different
kinds of tumour cells, particularly those which over-express eIF4E
or have deregulated PI3K, Akt or mTOR activity, are likely to
respond to the new generation of mTOR inhibitors and eIF4F
disrupting agents that are now being developed for use in cancer
therapy [44,61–63].
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